Cooper University Health Care Announces Major New $300 Million Gloucester Township Campus
Blackwood, New Jersey--(Newsfile Corp. - June 3, 2026) - Cooper University Health Care, the leading academic health system in southern New Jersey, today announced plans for a new multispecialty outpatient campus in Gloucester Township, a transformative $300 million investment that will expand access to advanced specialty care services for residents across the region. The nearly 184,000-square-foot, five-story Gloucester Township Campus will be built on 39 acres of undeveloped land adja
2026-06-03 6:00 PM EDT | Cooper University Health Care
Functional Brands Inc. Clears Barrier to $142.9 Million BullionFX | Alchemy Acquisition
Lake Oswego, Oregon--(Newsfile Corp. - June 3, 2026) - Functional Brands Inc. (NASDAQ: MEHA), announced that shareholders have voted to authorize the reverse stock split, removing an obstacle between the Company and the close of its $142.9 million acquisition of BullionFX | Alchemy, a gold-backed decentralized finance platform targeting retail, institutional, and blockchain markets. The Company's focus now shifts to closing the acquisition. All remaining acquisition closing conditions
Household / Consumer / Cosmetics, Health
2026-06-03 9:07 AM EDT | Functional Brands Inc.
Tersis Technologies Appoints Scott St. John Chief Strategic Development Officer
Brooksville, Florida--(Newsfile Corp. - June 3, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis" or the "Company"), a developer of regenerative waste-to-energy, carbon utilization, and circular economy technologies, today announced the appointment of Scott St. John as Chief Strategic Development Officer.
Agriculture, Energy, Alternative Energy, Health
2026-06-03 8:49 AM EDT | Tersis Technologies Inc.
TelyRx to Present at the Small Cap Growth Virtual Investor Conference June 4, 2026
Clearwater, Florida--(Newsfile Corp. - June 3, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that Vanessa Slowey, President and Chief Executive Officer, and John Cascio, Chief Financial Officer, will present live at the Small Cap Growth Virtual Investor Conference hosted by VirtualInvestorConferences.com, o
Healthcare and Hospitals, Health
2026-06-03 8:35 AM EDT | TelyRx
Restart Life Sciences Appoints Inez Ho as Chief Financial Officer
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce the appointment of Inez Ho as Chief Financial Officer (CFO) of the Company, effective immediately. Ms. Ho brings over 12 years of robust finance and accounting experience to Restart Life, with a strong track record of supporting publicly listed companies across diverse industries. Her deep areas of e
Technology, Biotechnology, Health
2026-06-03 6:00 AM EDT | Restart Life Sciences Corp.
Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors
Montreal, Quebec--(Newsfile Corp. - June 3, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the appointment of Dr. John Beaver to its Board of Directors. Dr. Beaver brings more than two decades of leadership experience across global pharmaceutical and biotechnology organizations. Dr. Beaver has held senior leadership position
Biotechnology, Pharmaceuticals, Health
2026-06-03 3:15 AM EDT | Defence Therapeutics Inc.
Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias)
Winter Park, Florida--(Newsfile Corp. - June 2, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) is thrilled to announce that the powerful new documentary showcasing TNA Wrestling star and former WWE superstar Jeff Sciullo, known to fans worldwide as Elias (or Elijah), is in final editing and racing toward release!
Healthcare and Hospitals, Health
2026-06-02 9:30 AM EDT | Adia Nutrition Inc.
Glow Lifetech Achieves Warrant-Free Capital Structure Following Elimination of 70 Million Warrants and 20% Reduction in Fully Diluted Shares
Toronto, Ontario--(Newsfile Corp. - June 2, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that all of its outstanding 8,900,000 share purchase warrants1 expired unexercised on May 29, 2026, fully eliminating the Company's warrant overhang. This milestone represents another important step in Glow's ongoing efforts to simplify its capital structure, reduce potential dilution, and enhance long-term
2026-06-02 7:30 AM EDT | Glow Lifetech Corp.
WELL Health Improves Guidance Based on WELL Canada Achieving $100 Million in Annualized Adjusted EBITDA Run-Rate Ahead of Schedule
WELL has reached its goal of $100 million in annualized Adjusted EBITDA(1) run-rate for WELL Canada, three calendar quarters ahead of schedule, driven by strong organic growth across WELL Clinics and WELLSTAR together with two accretive acquisitions. WELL had previously guided a $100 million annualized Adjusted EBITDA(1) run-rate by Q1-2027 on approximately $800 million of revenue. The Company has delivered it on approximately $700 million of revenue, implyi
Technology, Computer Software, Healthcare and Hospitals, Health
2026-06-02 6:30 AM EDT | WELL Health Technologies Corp.
CNA Brings 'Power of Nurses' to Winnipeg for National Conference
Ottawa, Ontario--(Newsfile Corp. - June 2, 2026) - The Canadian Nurses Association (CNA) will host the CNA Conference 2026 from September 21–23, 2026, at the RBC Convention Centre Winnipeg — the first CNA national conference in eight years. The three-day event will bring together nurses, health system leaders, researchers, and partners from across Canada and beyond. "The return of the CNA Conference provides an important opportunity for nurses from across Canada to come toge
2026-06-02 6:00 AM EDT | Canadian Nurses Association | Association des infirmières et infirmiers du Canada
L'AIIC met à l'honneur le « pouvoir des infirmières et infirmiers » à Winnipeg lors de sa conférence nationale
Ottawa, Ontario--(Newsfile Corp. - 2 juin 2026) - L'Association des infirmières et infirmiers du Canada (AIIC) tiendra la Conférence de l'AIIC 2026 du 21 au 23 septembre 2026 au RBC Convention Centre Winnipeg — la première conférence nationale de l'AIIC depuis huit ans. Cet événement de trois jours réunira des infirmières et infirmiers, des leaders du système de santé, des chercheurs et des partenaires provenant de partout au Canada et d
2026-06-02 6:00 AM EDT | Canadian Nurses Association | Association des infirmières et infirmiers du Canada
Promino(TM) Delivered to Stanley Cup Final Locker Room as Ambassador Jack Eichel Competes for Championship
Burlington, Ontario--(Newsfile Corp. - June 2, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a leader in muscle health and performance nutrition, is pleased to announce that a rush supply of Promino™ - NSF Certified for Sport® was recently supplied in connection with the Stanley Cup Final. The development comes as Promino Ambassador Jack Eichel continues to play a leading role in the Vegas Golden K
Food / Beverages, Sports, Health
2026-06-02 6:00 AM EDT | Promino Nutritional Sciences, Inc.
Charlotte's Web Appoints Jeff Raborn to Board of Directors
Louisville, Colorado--(Newsfile Corp. - June 1, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) (Charlotte's Web or the Company), a botanical wellness innovation company and a market leader in hemp extract wellness, is pleased to announce the appointment of Jeff Raborn to its Board of Directors, effective May 28, 2026. Mr. Raborn has been designated to the Board by BT DE Investments Inc. ("BAT"), a subsidiary of British American Tobacco p.l.c. (LSE: BATS)
2026-06-01 5:35 PM EDT | Charlotte's Web Holdings, Inc.
Edison Issues Report on Nabaltec (NTG)
London, United Kingdom--(Newsfile Corp. - June 1, 2026) - Edison issues report on Nabaltec (XETRA: NTG). Nabaltec is a German specialist chemicals business focused on aluminium hydroxide- and aluminium oxide-based products. Its products are used where customers require fire safety, smoke suppression, thermal management, electrical insulation and wear resistance. The company's largest segment, Functional Fillers, supplies halogen-free flame-retardant fillers, fine hydroxides, viscosity-o
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-06-01 10:09 AM EDT | Edison Group
QScreen AI Launches European Investor Roadshow Following Recent Strategic and Technology Milestones
Toronto, Ontario--(Newsfile Corp. - June 1, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, today announced that members of its senior leadership team will participate in a five-city investor roadshow across Central Europe from June 1 to June 5, 2026.
2026-06-01 7:03 AM EDT | QScreen AI Inc.
CBIH Completes Cannabinoid-Based Melanoma Patent Application Program Focused on Cannabinoid Science and Epigenetic Regulation
Houston, Texas--(Newsfile Corp. - June 1, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company focused on cannabinoid biotechnology, applied research, and therapeutic innovation, today announced the completion of a patent-ready melanoma research program focused on cannabinoid science, oncology biology, aging-related cellular stress, and epigenetic regulation. The Company views this milestone as part of its broader strategy to build research-driven int
Biotechnology, Pharmaceuticals, Cannabis, Health
2026-06-01 7:00 AM EDT | Cannabis Bioscience International Holdings
Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product
Northvale, New Jersey--(Newsfile Corp. - June 1, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today announced that it has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for a generic drug product in the class of medications called anticoagulants. IQVIA reported branded product sa
Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-01 7:00 AM EDT | Elite Pharmaceuticals, Inc.
Defence Therapeutics Appoints Antibody Drug Conjugates Pioneer Dr. John Lambert to Its Board of Directors
Montreal, Quebec--(Newsfile Corp. - June 1, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the appointment of Dr. John Lambert to its Board of Directors, effective immediately. Dr. Lambert brings more than four decades of scientific leadership and pioneering expertise in the development of antibody-drug conjugates ("ADCs"), f
Biotechnology, Pharmaceuticals, Health
2026-06-01 3:15 AM EDT | Defence Therapeutics Inc.
Delivra Health and Its Brands Dream Water(R) and LivRelief(TM) Report Results for Third Quarter of Fiscal 2026
Third quarter sales reflect the impact of the continued changes in the global geopolitical landscape that has temporarily impacted outbound shipments from the USA to the Middle East distribution partners Third quarter sales and year-to-date sales growth of Dream Water® Canada E-commerce of 16% and 13% respectively offset by a decline in Dream Water® Canada Retail of 15% and 6% respectively compared to same peri
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-05-29 5:45 PM EDT | Delivra Health Brands Inc.
Defence Therapeutics Strengthens Its Scientific Advisory Board with the Appointment of Dr. Sarkis Meterissian
Montreal, Quebec--(Newsfile Corp. - May 29, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, announces that Dr. Sarkis Meterissian resigned today from the Board of Directors of Defence to deepen engagement with the Company by joining the Scientific Advisory Board ("SAB"). Defence Therapeutics' current SAB is composed of Rob Leanna, PhD,
Biotechnology, Pharmaceuticals, Health
2026-05-29 4:30 PM EDT | Defence Therapeutics Inc.